Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae
By H. Yigit, A. Queenan, Gregory J. Anderson, A. Doménech-Sánchez, J. Biddle, Christine D. Steward, S. Albertí, K. Bush, F. Tenover. Antimicrobial Agents and Chemotherapy, 2001
1,361 citations recorded by the source corpus.
Subfields: Molecular Medicine, Pharmacology, Pollution
View Paper: https://www.semanticscholar.org/paper/e18d5469584d02e1e45748307dddb8417e9d4301
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Medicine
In Pharmacology
In Pollution
Citations in the corpus
- Carbapenemases: the Versatile β-Lactamases (2007, background): “However, the identification of plasmid-encoded IMP-1, a metallo- -lactamase in Pseudomonas aeruginosa (228), ARI-1 (OXA-23), a class D carbapenemase in Acinetobacter baumannii (157, 191), and KPC-1, a class A carbapenemase in Klebsiella pneumoniae (245), has changed the patterns of carbapenemase dis”
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions (2012, background): “It has been estimated that in 688 cmr.asm.org Clinical Microbiology Reviews Greek hospitals, some 10 to 15% of CPE (a bacterial population consisting mainly of KPC-2-producing K. pneumoniae strains) appear resistant by the CLSI interpretive criteria but susceptible according to EUCAST (Daikos, unpub”
- The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. (2014, background): “The IMI enzymes (IMIpenemhydrolyzing ß-lactamase) have been detected in rare isolates of Enterobacter spp. in USA [7], France [8], Croatia [9], Finland [10] and Argentina[11], and more recently a colistin-resistant ht tp :// do c. re ro .c h p Enterobacter asburiae isolate was recovered in Ireland [”
- Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. (2011, background): “Endimiani A, Carias LL, Hujer AM et al. (2008) Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.”
- Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance (2017, background): “The first qnr gene was discovered on a plasmid of K. pneumoniae isolated in 1994 in the United States (Martı́nez-Martı́nez, Pascual and Jacoby 1998).”
- The global epidemiology of carbapenemase-producing Enterobacteriaceae (2017, background): “in the United States was isolated from a patient in North Carolina.(21) This strain was identified through the Project”
- Carbapenem resistance: overview of the problem and future perspectives (2016, background): “First found in the late 1990s in the New York City area in the USA [Yigit et al. 2001], they soon spread to bordering states [Endimiani et al. 2009], Latin America [Villegas et al. 2006], and Israel [Leavitt et al. 2007].”
- Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods (2016, background): “KPCs have been the most frequently observed class A carbapenemases since their first description in the eastern the USA in 1996 (Yigit et al., 2001).”
- Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. (2005, neutral): “5 Resistant D (1) 32 32 32 8 1 Resistant E (1) 32 32 32 16 16 Resistant E (2) 32 32 32 8 2 Susceptible E (3) 32 32 32 16 8 Resistant F (1) 32 32 32 16 16 NA G (1) 32 32 32 4 2 Susceptible H (1) 32 32 32 16 4 Susceptible I (1) 32 32 32 16 16 Resistant A (1) 32 32 32 16 16 Resistant A (2) 32 32 32 16 ”